Sabra Health Care REIT, Inc.
NASDAQ:SBRAREIT - Healthcare Facilities
-$0.11 today
- Market cap
- $5.40B
- Beta
- 0.63
- P/E (TTM)
- 29.0
- EPS (TTM)
- $0.62
- Dividend yield
- 6.69%
Volume 2.42M
Average 2.46M
SBRA Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Sabra Health Care REIT, Inc.NASDAQ: SBRA
Stock-Based Compensation · Q2 FY2026 · quarter ended Jun 2026
Stock-based compensation growth accelerates
Q2 FY2026 stock-based compensation of $4.09M rose 51.2% year over year, ahead of the +24.6% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 32.0% from the prior quarter. Over 3 fiscal years it compounded at +15.1% a year.
Context
- Stock-based compensation amounted to 1.5% of revenue in FY2025, up 0.2 pp from a year earlier.
- Stock-based compensation increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +51.2% holds above the trailing-twelve-month pace of +24.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 11.36M USD
- Year-over-year change
- +26.4%
- 4-year CAGR
- +9.5%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 11.36M | +26.4% |
| FY2024 | 2024-12-31 | 8.99M | +13.5% |
| FY2023 | 2023-12-31 | 7.92M | +6.2% |
| FY2022 | 2022-12-31 | 7.45M | -5.8% |
| FY2021 | 2021-12-31 | 7.91M | — |
Stock-Based Compensation vs competitors
How SBRA compares with its peers on the latest reported figures
- SBRA's LTM Jun 2026 stock-based compensation of $13.13M is the 5th largest of the 11 companies compared; the peer median is $8.97M.
- Its year-over-year change of +24.6% is the 6th highest of 8, against a peer median of +126.3%.
- Stock-based compensation amounts to 1.5% of revenue for SBRA, versus a peer median of 1.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $1.56B | +2425.8% | +290.5% | 11.4% | |
| LTM Jun 2026 | $53.19M | +476.0% | +17.4% | 4.1% | |
| LTM Sep 2026 | $25.36M | +126.3% | +55.2% | 0.9% | |
| LTM Sep 2026 | $22.59M | +61.2% | -18.3% | 1.0% | |
| LTM Jun 2026 | $13.13M | +24.6% | +15.1% | 1.5% | |
| LTM Sep 2026 | $11.87M | +9.0% | +27.4% | 1.9% | |
| LTM Sep 2026 | $6.06M | — | — | 1.3% | |
NHPBPNational Healthcare Properties, Inc. | LTM Mar 2026 | $4.38M | +1043.1% | +47.0% | 1.3% |
NHPNational Healthcare Properties, Inc. (NHP) | LTM Dec 2025 | $3.77M | — | — | 1.1% |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | $2.4M | -93.2% | -19.5% | 0.2% |
| FY2025 | $0 | — | — | 0.0% | |
| Peer median (excluding SBRA) | $8.97M | +126.3% | +27.4% | 1.2% | |
Competitors are the stored peer set for SBRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (113.26M) | (77.61M) | 13.76M | 126.71M | 155.51M |
| Depreciation & Amortization | 178.99M | 187.78M | 183.09M | 169.62M | 187M |
| Deferred Income Tax | 227.84M | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 7.91M | 7.45M | 7.92M | 8.99M | 11.36M |
| Change in Working Capital | 22.7M | (19.69M) | (2.73M) | (22.55M) | (9.85M) |
| Accounts Receivables | 8.22M | (6.44M) | (11.08M) | (15.46M) | (11.45M) |
| Inventory | (8.22M) | 0 | 11.08M | 0 | 0 |
| Accounts Payables | 14.48M | 0 | 8.34M | (7.09M) | 1.6M |
| Other Working Capital | 8.22M | (13.25M) | (11.08M) | 0 | 0 |
| Other Non-Cash Items | 32.2M | 217.8M | 98.55M | 27.77M | 4.6M |
| Operating Cash Flow | 356.39M | 315.73M | 300.57M | 310.54M | 348.61M |
| Capital Expenditures | (33.61M) | 0 | 0 | 0 | 0 |
| Acquisitions (Net) | (7.77M) | (142.91M) | (5.24M) | (1.26M) | (1.24M) |
| Purchases of Investments | (9.06M) | (8.02M) | (11.02M) | (2.83M) | (9K) |
| Sales of Investments | 1.29M | 5.38M | 5.46M | 5.94M | 7M |
| Other Investing Activities | (287.05M) | (70.69M) | 113.93M | (110.86M) | (383.71M) |
| Investing Cash Flow | (336.2M) | (216.25M) | 103.13M | (109M) | (377.96M) |
| Debt Repayment | 23.86M | 122.78M | (94.13M) | 12.56M | 107.72M |
| Common Stock Issued | 308.71M | 0 | 0 | 86.12M | 227.78M |
| Common Stock Repurchased | 0 | (4.81M) | (2.68M) | 0 | 0 |
| Dividends Paid | (262.92M) | (277.16M) | (277.45M) | (280.15M) | (289.5M) |
| Other Financing Activities | (39.51M) | (2.52M) | (36.04M) | (94K) | (5.24M) |
| Financing Cash Flow | 30.14M | (161.71M) | (410.3M) | (181.56M) | 40.76M |
| Effect of Forex Changes | 29K | 268K | (614K) | (359K) | 391K |
| Net Change in Cash | 50.36M | (61.95M) | (7.21M) | 19.62M | 11.8M |
| Free Cash Flow | 322.78M | 315.73M | 300.57M | 310.54M | 348.61M |
Sabra Health Care REIT, Inc.
NASDAQ:SBRA
Intrinsic Alpha fair value
Locked
Current Price
$20.62
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.